I will remain invested here as well.
Krystal Biotech, Inc. (KRYS) meldete reported a profit for the first quarter that was up on the same period last year
The company's earnings totaled $55.93 million, or $1.83 per share. This compares to $35.73 million, or $1.20 per share, last year.
The company's turnover in this period increased by 32.0% to 116.36 million US dollars from 88.18 million US dollars in the previous year.
Krystal Biotech, Inc. earnings at a glance (GAAP):
-Revenues: $55.93 million vs. $35.73 million last year.
-EPS: $1.83 vs. $1.20 last year.
-Revenue: $116.36 million vs. $88.18 million last year.
Das Ergebnis von Krystal Biotech, Inc. steigt im ersten Quartal
